Amid a controversy sparked by nationwide liver-donor shortages and a fevered public policy debate, Beth Israel Deaconess Medical Center (BIDMC), a Harvard Medical School affiliate, announced the creation of a "multidisciplinary" liver medicine center to bring needed care to Boston-area liver patients.
The incoming chief of the new center, Dr. Maureen Martin, said she hopes her team of doctors, nurses and researchers will build the strongest program in Boston, "one that can serve as a model for the rest of the nation."
Martin said one of her objectives is opening Boston's first pediatric liver program at her center.
She also said she hopes to begin a "living-donor program" that transplants parts of the liver from one living person into the liver of another. Her center, she said, has recruited an expert in this field.
When the new center opens later this month, it will find itself embroiled in a national dispute over how to best handle the allocation of liver donations and transplants.
At the conflict's core is a proposal by U.S. Secretary of Health and Human Services, Dr. Donna E. Shalala.
Shalala wants to begin making donated livers available for the sickest patients across the nation--the sicker you are, wherever you are, the better chance you'll get a new liver.
The current policy allows only the sickest transplant candidates within the donor's geographic region to be given priority for the liver.
French Give $600,000 For Joint Cancer EffortHarvard and French researchers announced last week that they are joining together in a five-year project aimed at improving the
Visiting Committee Studies Beef Liver and DormitoriesA tray of fresh beef liver slid into place at the Lowell House dining hall at one o'clock this afternoon.
Experimenting With CareL ISA HILL of Aurora, Ill, is a suburban housewife who spends much of her time thinking of creative ways
An Outspoken DeanN EW DEAN of the School of Public Health Harvey V. Fineberg '67 has been grappling with questions about medical
Drug May Reduce Transplant DeathsAn experimental drug from pig intestinal tissue could reduce the number of deaths following stem cell transplants, Harvard Medical School
Students Run Marathon to Raise Money for Charity